This result is consistent with the results of two other studies that used NSCLC or HNSCC cell lines as tumor xenograft models.15, 16 In further investigation, honokiol inhibited FGF2 expression and activation of the FGFR1 signaling pathway in tumor xenografts. The gene discussed is FGF2; the disease is non-small cell lung carcinoma.